Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2021 Mar 22;11:675806. doi: 10.3389/fonc.2021.675806

Corrigendum: Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide

Monserrat Llaguno-Munive 1,2, Sebastián León-Zetina 1, Inés Vazquez-Lopez 1, María del Pilar Ramos-Godinez 3, Luis A Medina 4,5, Patricia Garcia-Lopez 1,*
PMCID: PMC8020595  PMID: 33828996

In the original article, there was a mistake in Figure 2. Wrong microscopy photographs were included in the Sham and Mif/Tz 3-week groups. The corrected Figure 2 appears below.

Figure 2.

Figure 2

Hematoxylin and eosin (H&E) staining analysis of glioma tissue. Hyperbasophilic cells (black arrow), hyperchromatics cells (red arrow), vessel proliferation (arrowhead), mitosis (blue arrow). The images are representative of three animals per treatment Scale bars = 50 mm.

The authors apologize for this mistake and state that this does not change the article’s scientific discussion and conclusions in any way. The original article has been updated.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES